Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS
Status:
Unknown status
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate systematic pre-antiretroviral cryptococcal antigen
screening and pre-emptive fluconazole therapy in antigen positive patients, as a strategy to
reduce morbidity and mortality due to AIDS associated cryptococcal meningitis in patients
starting antiretroviral therapy at <100 CD4 in Cameroon.
Phase:
N/A
Details
Lead Sponsor:
ANRS, Emerging Infectious Diseases French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Collaborators:
St George's, University of London Yaounde Central Hospital